Clinical Trials Directory

Trials / Completed

CompletedNCT03056547

Biomarkers in Dyspnea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To explore biological mechanisms in human model of induced dyspnea, in order to remove the source of dyspnoea, to modify cerebral impact and to allow the development of targeted therapies.

Detailed description

The aim of the study will be to identify a specific biology and immunology associated with dyspnoea. It will open therapeutic possibilities through a better understanding of the mechanisms of dyspnea. Healthy volunteers will underwent two types of dyspnea. The subjects will be first familiar with both types of dyspnea and dyspnea measurement scales. Different components of dyspnea will be measured. Blood tests will be performed at different times (before dyspnea, during dyspnea, 60 and 90 min after dyspnea)

Conditions

Interventions

TypeNameDescription
OTHERInduced dyspneaBiological samples will be assessed during and after breathing discomfort induced by laboratory models of dyspnea ("work/effort", "air hunger").

Timeline

Start date
2017-11-23
Primary completion
2019-01-08
Completion
2019-01-08
First posted
2017-02-17
Last updated
2019-09-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03056547. Inclusion in this directory is not an endorsement.

Biomarkers in Dyspnea (NCT03056547) · Clinical Trials Directory